Jaime Prat spends much of his time researching Pathology, Cancer research, Carcinoma, Carcinogenesis and Microsatellite instability. His research in Pathology intersects with topics in Molecular pathology, Ovarian cancer and Ovary. His research in Ovary tackles topics such as Fallopian tube which are related to areas like Peritoneal cancer.
His Cancer research study combines topics from a wide range of disciplines, such as Tumor suppressor gene, Cancer, Catenin and Exon. His Carcinoma research integrates issues from Gynecologic oncology, Radiology and Adenocarcinoma. His Carcinogenesis study combines topics in areas such as DNA methylation, Mutation, Single-strand conformation polymorphism, Gene mutation and Molecular biology.
His primary areas of investigation include Pathology, Cancer research, Carcinoma, Immunohistochemistry and Ovary. His Pathology research includes elements of Cancer, Internal medicine and Adenocarcinoma. His studies in Cancer research integrate themes in fields like Carcinogenesis, Tumor suppressor gene and PTEN.
His studies deal with areas such as Endometrial cancer, Molecular genetics, Serous carcinoma and Oncology as well as Carcinoma. His Immunohistochemistry research incorporates elements of Stromal cell and Monoclonal antibody. His biological study spans a wide range of topics, including Ovarian carcinoma, Ovarian tumor, Ovarian cancer and Fallopian tube.
Jaime Prat mostly deals with Pathology, Cancer research, Carcinoma, Ovary and Cancer. Jaime Prat works mostly in the field of Pathology, limiting it down to concerns involving Uterus and, occasionally, Mesenchymal stem cell. Jaime Prat conducts interdisciplinary study in the fields of Cancer research and Microsatellite instability through his research.
His work carried out in the field of Carcinoma brings together such families of science as Gynecologic oncology, Serous carcinoma, Endometrial cancer and PTEN. He combines subjects such as SMARCA4, Ovarian carcinoma, Ovarian cancer, Fallopian tube and Transitional Cell with his study of Ovary. The concepts of his Cancer study are interwoven with issues in Chromatin, Molecular biology and microRNA.
Jaime Prat mainly focuses on Carcinoma, Cancer research, Pathology, Ovary and Fallopian tube. He has researched Carcinoma in several fields, including Molecular genetics, Gynecologic oncology, Radiology and Endometrial cancer. His work deals with themes such as Epithelial–mesenchymal transition, Cytokeratin, Clear cell carcinoma and PTEN, which intersect with Cancer research.
His study of Immunohistochemistry is a part of Pathology. His Ovary research is multidisciplinary, incorporating elements of Carcinogenesis, Cancer, Ovarian carcinoma, Serous fluid and Peritoneum. His research integrates issues of Neoplasm staging and Peritoneal cancer in his study of Fallopian tube.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Manel Esteller;Jose Maria Silva;Gemma Dominguez;Felix Bonilla.
Journal of the National Cancer Institute (2000)
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
International Journal of Gynecology & Obstetrics (2014)
Uterine sarcomas: A review
Emanuela D'Angelo;Jaime Prat.
Gynecologic Oncology (2010)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.
Virchows Archiv (2012)
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla;Jonathan S. Berek;Mauricio Cuello Fredes;Lynette A. Denny.
International Journal of Gynecology & Obstetrics (2019)
FIGO staging for uterine sarcomas
International Journal of Gynecology & Obstetrics (2009)
Molecular pathology of endometrial hyperplasia and carcinoma.
Xavier Matias-guiu;Lluis Catasus;Elena Bussaglia;Helena Lagarda.
Human Pathology (2001)
A DNA methylation fingerprint of 1628 human samples
Augustin F. Fernandez;Yassen Assenov;Jose Ignacio Martin-Subero;Balazs Balint.
Genome Research (2012)
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.
Journal of Gynecologic Oncology (2015)
Prognostic parameters of endometrial carcinoma.
Human Pathology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: